Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624293 · ClinicalTrials.gov registry record
Access BNP Clinical Enrollment Study
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 1,100
- Enrollment target
NCT06624293: Completed study, sponsored by Beckman Coulter.
NCT06624293 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 1,100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06624293 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 1,100 participants
- Enrollment target
Study Summary
The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.
Primary Outcome
Subjects with BNP value above clinical decision point
Interventions
- DIAGNOSTIC_TEST BNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-08-30 |
| Est. Completion | 2025-02-18 |
What the finished NCT06624293 record still lists
NCT06624293 is an observational study that tracks outcomes without assigning an intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which BNP is the first listed.
NCT06624293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06624293 about?
NCT06624293 is a clinical study titled "Access BNP Clinical Enrollment Study". The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.
What is the current status of trial NCT06624293?
This trial is currently completed. The enrollment target is 1,100 participants. The study started on 2024-08-30. Estimated completion is 2025-02-18.
What interventions are being tested in trial NCT06624293?
The interventions under investigation include: BNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06624293?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI